These findings will be fundamental for designing appropriate pharmacological interventions to prevent infection with SARS-CoV-2 or dampen the severity of COVID-19 and will help to better understand how the IFN landscape affects human immune responses to respiratory viral infections. The gene discussed is IFNA1; the disease is infection.